INVESTMENT PORTAL
OF RUSSIAN REGIONS
0%
LOADING DATA
РУС | ENG | 中文

Production of "NewMan" hemostatic devices for interventional cardiology

Description

The dual-circuit design (two independent chambers) technically ensures "passable hemostasis"; the radial artery occlusion rate is 1.7% according to pilot use data (ultrasound at 24 hours, 300 patients). There is a Roszdravnadzor registration certificate and RF patent No. 2815354.

Publication date: 21.10.2026 Last updated: 21.10.2026

Share

Production of "NewMan" hemostatic devices for interventional cardiology

Region

Москва

Industry

Медицина, здравоохранение и фармацевтическая промышленность

Project type

Export of products, Expansion of existing production

Project budget

59,5 mln ₽

detailed project information

Description

About the project

The dual-circuit design (two independent chambers) technically ensures "passable hemostasis"; the radial artery occlusion rate is 1.7% according to pilot use data (ultrasound at 24 hours, 300 patients). There is a Roszdravnadzor registration certificate and RF patent No. 2815354.

Description of project services or products

Russian hemostatic bracelet "NewMan".

Project company: Academy of Innovators. ANO "Human Capital Development" (website)

Investment indicators

Project budget

59,5 mln ₽

IRR

70%

NPV

131 mln ₽

PBP

36 months

Equity share in the project budget

7%

Government support

Foundation for Assistance to Innovations: grants, Skolkovo Foundation: resident and compensation of marketing costs, Government of Moscow: 'Moscow Innovator' award, Moscow Innovation Agency: grant for piloting at City Clinical Hospital No. 1, support from the Moscow Innovation Cluster. Included in the register of small technology companies.

Investments in the project

40 mln ₽

total investment volume